BioArk Partners

ARK Capital is a leading boutique investment bank dedicated to partnering with clients through all market cycles. Founded in 2022 with offices in Shanghai and Beijing, we offer comprehensive advisory services in Private Placement, Business Development and Licensing (BD&L), and Mergers & Acquisitions (M&A). Our deep industry expertise in biotechnology, medical devices, synthetic biology, and technology enables us to deliver tailored solutions that drive growth and create long-term value.